REYKJAVIK, Iceland, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today the completion of the equity transaction …
Partners Alvotech and STADA have marketing authorization application (MAA) for ustekinumab accepted for filing by the European Medicines Agency (EMA) BAD VILBEL, HESSEN, GERMANY, February 9, 2023 /EINPresswire.com/ -- EMA Confirms Acceptance of …
Partners Alvotech and STADA have marketing authorization application (MAA) for ustekinumab accepted for filing by the European Medicines Agency (EMA) EMA opinion on AVT04 could come as soon as the second half of 2023 Reference product Stelara® (ustekinumab …
Advanz Pharma will commercialize AVT23, a proposed biosimilar to Xolair® (omalizumab) in the European Economic Area, UK, Switzerland, Canada, Australia, and New Zealand REYKJAVIK, Iceland, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global …
AVT02 as Simlandi™ is the first biosimilar approved under the strategic partnership between Alvotech and Bioventure REYKJAVIK, Iceland and DUBAI, United Arab Emirates, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) and Bioventure, a wholly …
REYKJAVIK, Iceland, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the completion of a private placement of …
Proceeds of global competition's new category to benefit The Michael James Jackson Foundation to fund scholarships for people of color entering brewing industry MELVILLE, NEW YORK, USA, January 16, 2023 /EINPresswire.com/ -- In the spirit of giving, …
REYKJAVIK, Iceland and TOKYO, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Japanese pharmaceutical company Fuji …
REYKJAVIK, Iceland, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today the initiation of a pharmacokinetic …
Results show Automated Pupillometer and NPi® can be used for patient evaluation and triage without risk of confounding by key intoxicants of abuse IRVINE, CALIF., USA, January 10, 2023 /EINPresswire.com/ -- A newly published clinical study shows that …
The U.S. Food and Drug Administration’s (FDA) regulatory review is anticipated to be completed in the second half of 2023 Stelara® (ustekinumab) is prescribed to treat a variety of inflammatory conditions REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 06, …
U.S. Food and Drug Administration (FDA) has confirmed that the goal date for an approval decision on Alvotech’s license application for AVT02 is April 13, 2023 FDA has completed review of Alvotech’s application of AVT02 as an interchangeable to high- …
Reference is made to the announcement issued earlier today about the completion of a private placement of subordinated convertible bonds. The aggregate principal amount is approximately US$70 million, instead of US$59.7 million. Please see correction below …
REYKJAVIK, Iceland, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced completion of a private placement of …
REYKJAVÍK, Iceland, Dec. 14, 2022 (GLOBE NEWSWIRE) -- It was the end of 2021 when Icewear announced its greatest innovation after almost 50 years in business. In partnership with Ístex, Icewear launched a new outdoor line with unique and sustainable …
The Neurological Pupil index™ (NPi®) and automated NPi pupillometry globally emerging as important for use in patients following cardiac arrest IRVINE, CALIFORNIA, USA, December 13, 2022 /EINPresswire.com/ -- NeurOptics’ Neurological Pupil index™ (NPi®) …
Sofokus, a digital business expert group, founded an investment company Digital Heart Capital II for early-stage startups with digital core solutions. TURKU, FINLAND, December 12, 2022 /EINPresswire.com/ -- Sofokus, a digital business expert group from …
REYKJAVÍK, Iceland, Dec. 10, 2022 (GLOBE NEWSWIRE) -- Iceland has been a popular tourist destination for generations, and the reasons are as diverse as the tourists. Iceland is patently scenic. Most Icelandic landscapes are uninterrupted by cities (or …
Robert Wessman Founder and Executive Chairman will ring the Nasdaq Iceland closing bell at 15:30 GMT on December 8, 2022 Listing on the Main Market can increase visibility, which may allow the company to appear in both domestic and global indexes Alvotech …
Hukyndra® (adalimumab) launches in Belgium, Bulgaria, Croatia, Czech Republic, Latvia, Romania, and Slovenia, increasing availability of high-concentration, citrate-free adalimumab in Europe Follows initial introduction of Hukyndra in nine countries: …
